CHIARADONNA, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 8.372
EU - Europa 7.499
AS - Asia 4.826
SA - Sud America 691
AF - Africa 136
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.547
Nazione #
US - Stati Uniti d'America 8.026
SE - Svezia 2.202
SG - Singapore 1.695
IT - Italia 1.632
CN - Cina 1.188
DE - Germania 1.050
RU - Federazione Russa 682
VN - Vietnam 564
HK - Hong Kong 522
BR - Brasile 519
PL - Polonia 345
IE - Irlanda 283
CA - Canada 275
GB - Regno Unito 270
FR - Francia 263
IN - India 172
UA - Ucraina 171
FI - Finlandia 150
NL - Olanda 105
KR - Corea 92
TR - Turchia 92
ID - Indonesia 82
BD - Bangladesh 79
AT - Austria 74
AR - Argentina 68
DK - Danimarca 65
IQ - Iraq 51
JP - Giappone 51
ES - Italia 49
ZA - Sudafrica 49
MX - Messico 46
CH - Svizzera 33
BE - Belgio 32
SA - Arabia Saudita 27
PK - Pakistan 25
EC - Ecuador 23
PH - Filippine 23
IR - Iran 21
UZ - Uzbekistan 21
CO - Colombia 19
MA - Marocco 19
CZ - Repubblica Ceca 16
PT - Portogallo 15
VE - Venezuela 15
JO - Giordania 14
CL - Cile 13
PY - Paraguay 13
TN - Tunisia 13
AU - Australia 12
EG - Egitto 12
TW - Taiwan 12
NP - Nepal 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
MY - Malesia 9
PE - Perù 9
UY - Uruguay 9
AZ - Azerbaigian 8
LU - Lussemburgo 8
AL - Albania 7
KE - Kenya 7
KG - Kirghizistan 7
LT - Lituania 7
PS - Palestinian Territory 7
ET - Etiopia 6
GR - Grecia 6
HU - Ungheria 6
JM - Giamaica 6
LB - Libano 6
OM - Oman 6
RO - Romania 6
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
KZ - Kazakistan 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BO - Bolivia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
MN - Mongolia 3
NI - Nicaragua 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
QA - Qatar 2
RS - Serbia 2
Totale 21.524
Città #
Stockholm 1.882
Ann Arbor 1.229
Singapore 1.016
Ashburn 781
Frankfurt am Main 696
San Jose 586
Milan 509
Woodbridge 501
Hong Kong 491
Fairfield 404
Wilmington 342
Chandler 337
Houston 291
Kraków 280
Dublin 275
Dallas 241
New York 203
Beijing 201
Los Angeles 175
Jacksonville 168
Dearborn 167
Seattle 162
Ho Chi Minh City 160
Hefei 159
Santa Clara 157
Cambridge 146
Toronto 136
Munich 132
Chicago 123
The Dalles 121
Hanoi 118
Seoul 87
Princeton 84
Council Bluffs 80
Buffalo 79
Helsinki 77
Lauterbourg 70
Jakarta 66
Nanjing 62
Shanghai 61
São Paulo 60
Moscow 52
Vienna 51
Dong Ket 49
Rome 48
Guangzhou 45
Boardman 44
Warsaw 44
Lawrence 42
Montréal 38
San Diego 37
Tokyo 35
Montreal 33
Orem 33
Altamura 32
Cento 32
Chennai 31
Johannesburg 31
Denver 30
Atlanta 29
Brussels 29
Nuremberg 29
Da Nang 28
Lachine 28
Turin 27
Baghdad 25
Bologna 25
London 25
Nanchang 25
Brooklyn 23
Poplar 22
Tianjin 21
Amsterdam 20
Torino 20
Ankara 19
Naples 19
Zhengzhou 19
Andover 18
Falls Church 18
Paris 18
Zurich 18
Hyderabad 17
Manchester 17
Rio de Janeiro 17
Salt Lake City 17
Tashkent 17
Kent 16
Boston 14
Brusuglio 14
Dhaka 14
Kunming 14
Amman 13
Hebei 13
Huizen 13
Lappeenranta 13
Mumbai 13
Phoenix 13
Sacramento 13
Bexley 12
Florence 12
Totale 14.399
Nome #
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 2.682
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 702
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 677
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells 533
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3) 489
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 464
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring. 458
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation 448
Central metabolism of functionally heterogeneous mesenchymal stromal cells 402
From cancer metabolism to new biomarkers and drug targets 398
Mitochondria in Focus: Targeting the Cell-Death Mechanism 384
Analysis of mitochondrial metabolism in situ: Combining stable isotope labeling with selective permeabilization 384
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability 364
RAS and PKA pathways in cancer: new insight from transcriptional analysis 361
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 359
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 335
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor 333
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells 331
Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts 327
Ras-dependent carbon metabolism and transformation in mouse fibroblasts 318
Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes 313
Metabolic reprogramming and dysregulated metabolism: Cause, consequence and/or enabler of environmental carcinogenesis? 313
Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS 303
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 303
New Insights into the Connection between Histone Deacetylases, Cell Metabolism, and Cancer 295
Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes 293
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response 293
Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-ras transformed fibroblasts 282
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 282
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration 276
Acquired glucose sensitivity of k-ras transformed fibroblasts 274
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 273
Cancer Metabolism as a New Real Target in Tumor Therapy 273
Genetic and Molecular Characterization of The Human Osteosarcoma 3AB-OS Cancer Stem Cell Line: A Possible Model For Studying Osteosarcoma Origin and Stemness 269
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 268
Systems biology and the molecular circuits of cancer 266
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 259
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells 258
Mitochondrial Complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death 258
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer 258
Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation 257
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells 254
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer 253
PKA stimulation protects K-ras transformed cells from apoptosis induced by glucose depletion reactivating mitochondrial function 249
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials 239
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 233
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 224
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 215
Glucose shortage dependent apoptosis in transformed cells upon activation of UPR-autophagy pathway 207
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 202
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2 198
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 193
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 185
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 185
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism 173
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 171
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 170
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 160
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 157
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells 140
Comparative transcriptional analysis between a K-ras cell model of transformation and the NCI60 human cancer cells collection 139
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 138
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 133
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 126
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 124
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 112
High throughput metabolomics analysis in normal and K-Ras transformed murine fibroblasts 111
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 92
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 87
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 86
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 86
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 85
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 82
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 77
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 73
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 68
Histone glycation: a novel epigenetic target in breast cancer 50
null 3
Totale 22.095
Categoria #
all - tutte 56.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021328 0 0 0 0 0 0 0 0 0 0 125 203
2021/20221.055 107 94 124 110 87 91 59 43 53 43 101 143
2022/20231.440 157 403 162 156 104 183 11 78 102 6 59 19
2023/2024975 24 38 27 79 100 217 203 44 65 34 23 121
2024/20253.104 176 254 296 141 214 140 255 156 265 447 307 453
2025/202610.223 737 467 770 940 1.139 852 1.225 357 848 2.608 280 0
Totale 22.095